Navigation Links
Johns Hopkins to participate in 1000 Genomes Project
Date:1/22/2008

Researchers at the McKusick-Nathans Institute of Genetic Medicine (IGM) at Johns Hopkins will join other national and international scientists in the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of numerous people from around the world to create the most detailed and medically useful picture to date of human genetic variation.

We have made considerable headway in creating a map of common DNA variation in humans, the HapMap Project, and applied it with great success toward understanding many common diseases, says Aravinda Chakravarti, Ph.D., professor of medicine, pediatrics and molecular biology and genetics at Hopkins and a member of the IGM. It is apparent that more detailed maps will speed up disease gene discovery for the many illnesses we still fail to understand. Its crucial to complete the catalog of common variation in DNA, the small fraction of genetic material that varies among people and leads to differences in susceptibility to disease, drug response or reaction to environmental factors, and the 1000 Genomes project will home in on these differences.

By sequencing the genomes of at least 1,000 people, the project will produce a catalog of genetic variants that are present at 1 percent or greater frequency in the human population across most the genome. The 1000 Genomes Project builds on the human haplotype map - a map of genetic variants - developed by the International HapMap Project. The HapMap already has helped researchers discover more than 100 regions of the genome containing genetic variants associated with risk of common human diseases, such as diabetes, age-related macular degeneration, prostate and breast cancer, and coronary artery disease, including work at Johns Hopkins on sudden cardiac death.

The new map will give researchers important clues to which genetic variants might be causal, including more precise information on where to search for causal variants.

Th
'/>"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Ravenell named recipient of grant from Robert Wood Johnson Foundation
2. Johnson City Medical Center Begins Offering Einstein Bros. Menu Items at Second On Campus Location
3. Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
4. Bobby Rush Revue and James Super Chikan Johnson Announced for Post-Race Concert
5. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
6. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
7. Wendy Borow-Johnson to Join bioMETRX Board of Directors
8. Sixteen Organizations Implement ACG Rx-PM Predictive Modeling from Johns Hopkins University, DST Health Solutions
9. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
10. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
11. UAN Mourns Passing of President Cheryl L. Johnson, RN
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8FDA Acknowledges Mistakes in Knee Device Approval 58323 1FDA Acknowledges Mistakes in Knee Device Approval 58323 2Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 1Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 2Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 1Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 2